Search research articles
Contact Us
Filters
Showing results (71-80 of 135) with videos related to
Page
of 14
Sort By:
Journal of the American Chemical Society
|
July 14, 2007
How can a single second sphere amino acid substitution cause reduction midpoint potential changes of hundreds of millivolts?
Emine Yikilmaz, Jason Porta, Laurie E Grove, et al.
Arthritis Care & Research
|
February 14, 2023
Socioeconomic, Disease-Related, and Personal Factors Associated With Participation in Remote Follow-Up in Rheumatoid Arthritis: A Cross-Sectional Study
Liv M V Schougaard, Line R Knudsen, Birgith E Grove, et al.
Clinical and Translational Science
|
February 29, 2024
Knowledge and attitudes on implementing cardiovascular pharmacogenomic testing
Callan Russell, MaryAnn Campion, Megan E Grove, et al.
Journal of Computational Chemistry
|
February 3, 2016
Focused grid-based resampling for protein docking and mapping
Artem B Mamonov, Mohammad Moghadasi, Hanieh Mirzaei, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
August 3, 2011
Structural conservation of druggable hot spots in protein-protein interfaces
Dima Kozakov, David R Hall, Gwo-Yu Chuang, et al.
Molecular Biology of the Cell
|
August 9, 2013
VX-809 corrects folding defects in cystic fibrosis transmembrane conductance regulator protein through action on membrane-spanning domain 1
Hong Yu Ren, Diane E Grove, Oxana De La Rosa, et al.
International Journal of Antimicrobial Agents
|
July 3, 2017
Population pharmacokinetics of cefepime in febrile neutropenia: implications for dose-dependent susceptibility and contemporary dosing regimens
Nathaniel J Rhodes, Meagan E Grove, Patrick J Kiel, et al.
Leukemia & Lymphoma
|
June 11, 2014
Allogeneic transplant following brentuximab vedotin in patients with relapsed or refractory Hodgkin lymphoma and systemic anaplastic large cell lymphoma
Tim Illidge, Reda Bouabdallah, Robert Chen, et al.
NPJ Genomic Medicine
|
December 15, 2020
Clinical utility of genomic sequencing: a measurement toolkit
Robin Z Hayeems, David Dimmock, David Bick, et al.
Journal of Clinical Pharmacology
|
June 12, 2013
CYP3A-mediated drug-drug interaction potential and excretion of brentuximab vedotin, an antibody-drug conjugate, in patients with CD30-positive hematologic malignancies
Tae H Han, Ajay K Gopal, Radhakrishnan Ramchandren, et al.
Page
of 14
Search research articles
Search
Showing results (71-80 of 135) with videos related to
Sort By:
Page
of 14
Journal of the American Chemical Society
|
July 14, 2007
How can a single second sphere amino acid substitution cause reduction midpoint potential changes of hundreds of millivolts?
Emine Yikilmaz, Jason Porta, Laurie E Grove, et al.
Arthritis Care & Research
|
February 14, 2023
Socioeconomic, Disease-Related, and Personal Factors Associated With Participation in Remote Follow-Up in Rheumatoid Arthritis: A Cross-Sectional Study
Liv M V Schougaard, Line R Knudsen, Birgith E Grove, et al.
Clinical and Translational Science
|
February 29, 2024
Knowledge and attitudes on implementing cardiovascular pharmacogenomic testing
Callan Russell, MaryAnn Campion, Megan E Grove, et al.
Journal of Computational Chemistry
|
February 3, 2016
Focused grid-based resampling for protein docking and mapping
Artem B Mamonov, Mohammad Moghadasi, Hanieh Mirzaei, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
August 3, 2011
Structural conservation of druggable hot spots in protein-protein interfaces
Dima Kozakov, David R Hall, Gwo-Yu Chuang, et al.
Molecular Biology of the Cell
|
August 9, 2013
VX-809 corrects folding defects in cystic fibrosis transmembrane conductance regulator protein through action on membrane-spanning domain 1
Hong Yu Ren, Diane E Grove, Oxana De La Rosa, et al.
International Journal of Antimicrobial Agents
|
July 3, 2017
Population pharmacokinetics of cefepime in febrile neutropenia: implications for dose-dependent susceptibility and contemporary dosing regimens
Nathaniel J Rhodes, Meagan E Grove, Patrick J Kiel, et al.
Leukemia & Lymphoma
|
June 11, 2014
Allogeneic transplant following brentuximab vedotin in patients with relapsed or refractory Hodgkin lymphoma and systemic anaplastic large cell lymphoma
Tim Illidge, Reda Bouabdallah, Robert Chen, et al.
NPJ Genomic Medicine
|
December 15, 2020
Clinical utility of genomic sequencing: a measurement toolkit
Robin Z Hayeems, David Dimmock, David Bick, et al.
Journal of Clinical Pharmacology
|
June 12, 2013
CYP3A-mediated drug-drug interaction potential and excretion of brentuximab vedotin, an antibody-drug conjugate, in patients with CD30-positive hematologic malignancies
Tae H Han, Ajay K Gopal, Radhakrishnan Ramchandren, et al.
Page
of 14